Regulatory News
Monday, November 14, 2016
BRIEF-First patient enrolled in Mallinckrodt phase 4 trial of H.P. Acthar gel
* First patient enrolled in Mallinckrodt phase 4 trial of
H.P. Acthar gel for rheumatoid arthritis
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment